We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

2 hedge funds and large institutions have $24K invested in NeuroDerm Ltd. Ordinary Shares in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% less funds holding

Funds holding: 5 → 2 (-3)

98% less capital invested

Capital invested by funds: $1.3M → $24K (-$1.27M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VOAM
Vertex One Asset Management
British Columbia, Canada
-$1.13M
2
OTC
Opera Trading Capital
France
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$23K – – –
FWM
2
Focused Wealth Management
New York
$1K – – –
VOAM
3
Vertex One Asset Management
British Columbia, Canada
– -$1.13M -29,200 Closed
OTC
4
Opera Trading Capital
France
– -$141K -3,611 Closed

NDRM Hedge Fund Activity: Q1 2018 in Review

2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q1 2018, worth a combined $24K — down 98% from $1.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NDRM and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vertex One Asset Management, exiting entirely with an estimated $1.13M sold.

  • 2 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q1 2018, down from 5 in Q4 2017.
  • Funds reported $24K of NeuroDerm Ltd. Ordinary Shares stock for Q1 2018, down 98% quarter-over-quarter.
  • 0 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q1 2018 and 3 closed out, a net change of -3 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q1 2018 was Vertex One Asset Management, an estimated $1.13M sold.

Based on aggregated 13F filings for Q1 2018.